Journal of International Oncology ›› 2015, Vol. 42 ›› Issue (11): 817-820.doi: 10.3760/cma.j.issn.1673422X.2015.11.005

Previous Articles     Next Articles

Correlation of expression of Oct4 and tumorigenesis and prognosis of colorectal cancer

Zhou Huan, Hu Yu, Ren Feng, Mao Yong, Qi Xiaowei, Zhang Xueguang.   

  1. Department of Clinical Laboratory, Forth People′s Hospital of Wuxi City, Affiliated Hospital of Jiangnan University, Jiangsu Province, Wuxi 214062, China
  • Online:2015-11-08 Published:2015-09-30
  • Contact: Zhou Huan E-mail:hanson016@163.com

Abstract: ObjectiveTo study dynamic expression of Oct4 during development of colorectal cancer (CRC) and investigate the association between Oct4 expression and prognosis of patients with CRC. MethodsCRC tissues, matched nontumor tissues and colonic polyp tissues were collected and Oct4 expressions were analyzed by quantitative reverse transcriptionpolymerase chain reaction (qRTPCR), flow cytometry analysis (FCM) and immunohistochemistry (IHC). Medical records of patients with CRC were reviewed. Clinicopathological analysis was performed to assess the association between Oct4 expression and certain clinicopathological parameters. KaplaneMeier survival curve was conducted to evaluate association between Oct4 expression and survival time of patients with CRC. ResultsThe results of qRTPCR showed that the relative expressions of Oct4 mRNA in matched nontumor, colonic polyp and CRC tissues were (0.23±0.16)×10-5, (1.19±0.76)×10-5 and (3.79±1.94)×10-5 respectively, with a significant difference (F=8.633, P=0.001). IHC analysis displayed that the positive expression ratios of Oct4 in matched nontumor tissues, colonic polyp tissues and CRC tissues were 4.43%, 12.68% and 40.51% respectively, and a significant difference was discovered among them (χ2=66.311, P<0.001). Oct4 expression in CRC was significantly correlated with pathological stage (χ2=7.248, P=0.007), lymph node metastasis (χ2=4.888, P=0.027), distant metastasis (χ2=5.732, P=0.017) and TNM stage (χ2=4.174, P=0.041). KaplanMeier survival curve analysis demonstrated that Oct4 positive cases had a shorter median survival time (37.0 months) compared with Oct4 negative cases (76.0 months), with a significant difference (χ2=14.050, P=0.001). ConclusionThe expression of Oct4 is stepwise increased during development of CRC. The abnormal expression of Oct4 may play certain roles in the development of CRC. Oct4 may be an important biomarker for the clinical diagnosis, assessment of disease and prognosis in CRC.

Key words: Colorectal neoplasms, Colonic polyps, Oct4